The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
A ROR1–HER3–lncRNA signalling axis modulates the Hippo–YAP pathway to regulate bone metastasis
Open accessAbstract
Bone metastases remain a serious health concern because of limited therapeutic options. Here, we report that crosstalk between ROR1–HER3 and the Hippo–YAP pathway promotes breast cancer bone metastasis in a long noncoding RNA-dependent fashion. Mechanistically, the orphan receptor tyrosine kinase ROR1 phosphorylates HER3 at a previously unidentified site Tyr1307, following neuregulin stimulation, independently of other ErbB family members. p-HER3 Tyr1307 recruits the LLGL2–MAYA–NSUN6 RNA–protein complex to methylate Hippo/MST1 at Lys59. This methylation leads to MST1 inactivation and activation of YAP target genes in tumour cells, which elicits osteoclast differentiation and bone metastasis. Furthermore, increased ROR1, p-HER3 Tyr1307 and MAYA levels correlate with tumour metastasis and unfavourable outcomes. Our data provide insights into the mechanistic regulation and linkage of the ROR1–HER3 and Hippo–YAP pathway in a cancer-specific context, and also imply valuable therapeutic targets for bone metastasis and possible therapy-resistant tumours.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
Engelman, J. A., Zejnullahu, K., Mitsudomi, T., Song, Y., Hyland, C., Park, J. O., Lindeman, N., Gale, C.-M., Zhao, X., Christensen, J., et al. (2007) · Science · doi:10.1126/science.1141478 · Cited by 4,496
Genes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,597
The Hippo Signaling Pathway in Development and Cancer
Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,269
Insights into RNA Biology from an Atlas of Mammalian mRNA-Binding Proteins
Castello, A., Fischer, B., Eichelbaum, K., Horos, R., Beckmann, B. M., Strein, C., Davey, N. E., Humphreys, D. T., Preiss, T., Steinmetz, L. M., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.031 · Cited by 2,132
The Hippo pathway and human cancer
Harvey, K. F., Zhang, X., & Thomas, D. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3458 · Cited by 1,842
The Biology of YAP/TAZ: Hippo Signaling and Beyond
Piccolo, S., Dupont, S., & Cordenonsi, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00005.2014 · Cited by 1,802
Mechanisms of Hippo pathway regulation
Meng, Z., Moroishi, T., & Guan, K.-L. (2016) · Genes & Development · doi:10.1101/gad.274027.115 · Cited by 1,667
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Yu, F.-X., Zhao, B., Panupinthu, N., Jewell, J. L., Lian, I., Wang, L. H., Zhao, J., Yuan, H., Tumaneng, K., Li, H., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.037 · Cited by 1,628
The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells
Cordenonsi, M., Zanconato, F., Azzolin, L., Forcato, M., Rosato, A., Frasson, C., Inui, M., Montagner, M., Parenti, A. R., Poletti, A., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.048 · Cited by 1,381
The Hippo pathway: regulators and regulations.
Yu, F.-X., & Guan, K.-L. (2013) · Genes & Development · doi:10.1101/gad.210773.112 · Cited by 1,231
Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth
Zanconato, F., Forcato, M., Battilana, G., Azzolin, L., Quaranta, E., Bodega, B., Rosato, A., Bicciato, S., Cordenonsi, M., & Piccolo, S. (2015) · Nature Cell Biology · doi:10.1038/ncb3216 · Cited by 1,219
The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
Zhao, B., Tumaneng, K., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2303 · Cited by 1,205
The emerging roles of YAP and TAZ in cancer
Moroishi, T., Hansen, C. G., & Guan, K.-L. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3876 · Cited by 1,145
The STAT3-Binding Long Noncoding RNA lnc-DC Controls Human Dendritic Cell Differentiation
Wang, P., Xue, Y., Han, Y., Lin, L., Wu, C., Xu, S., Jiang, Z., Xu, J., Liu, Q., & Cao, X. (2014) · Science · doi:10.1126/science.1251456 · Cited by 1,105
Nuclear localization of EGF receptor and its potential new role as a transcription factor
Lin, S.-Y., Makino, K., Xia, W., Matin, A., Wen, Y., Kwong, K. Y., Bourguignon, L., & Hung, M.-C. (2001) · Nature Cell Biology · doi:10.1038/ncb0901-802 · Cited by 1,064
Self-citationEscape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3
Sergina, N. V., Rausch, M., Wang, D., Blair, J., Hann, B., Shokat, K. M., & Moasser, M. M. (2007) · Nature · doi:10.1038/nature05474 · Cited by 991
Transduction of mechanical and cytoskeletal cues by YAP and TAZ
Halder, G., Dupont, S., & Piccolo, S. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3416 · Cited by 985
Liu, B., Sun, L., Liu, Q., Gong, C., Yao, Y., Lv, X., Lin, L., Yao, H., Su, F., Li, D., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.004 · Cited by 908
The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment
Johnson, R., & Halder, G. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4161 · Cited by 881
Metabolic control of YAP and TAZ by the mevalonate pathway
Sorrentino, G., Ruggeri, N., Specchia, V., Cordenonsi, M., Mano, M., Dupont, S., Manfrin, A., Ingallina, E., Sommaggio, R., Piazza, S., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb2936 · Cited by 776
A Strategy for Probing the Function of Noncoding RNAs Finds a Repressor of NFAT
Willingham, A. T., Orth, A. P., Batalov, S., Peters, E. C., Wen, B. G., Aza-Blanc, P., Hogenesch, J. B., & Schultz, P. G. (2005) · Science · doi:10.1126/science.1115901 · Cited by 729
Alternative Wnt Signaling Activates YAP/TAZ
Park, H. W., Kim, Y. C., Yu, B., Moroishi, T., Mo, J.-S., Plouffe, S. W., Meng, Z., Lin, K. C., Yu, F.-X., Alexander, C. M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.013 · Cited by 705
Posttranscriptional Gene Regulation by Long Noncoding RNA
Yoon, J.-H., Abdelmohsen, K., & Gorospe, M. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.11.024 · Cited by 628
YAP and TAZ: a nexus for Hippo signaling and beyond
Hansen, C. G., Moroishi, T., & Guan, K.-L. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.05.002 · Cited by 574
The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer
Lin, A., Li, C., Xing, Z., Hu, Q., Liang, K., Han, L., Wang, C., Hawke, D. H., Wang, S., Zhang, Y., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3295 · Cited by 565
Self-citationAMPK modulates Hippo pathway activity to regulate energy homeostasis
Wang, W., Xiao, Z.-D., Li, X., Aziz, K. E., Gan, B., Johnson, R. L., & Chen, J. (2015) · Nature Cell Biology · doi:10.1038/ncb3113 · Cited by 549
Basic Mechanisms Responsible for Osteolytic and Osteoblastic Bone Metastases
Guise, T. A., Mohammad, K. S., Clines, G., Stebbins, E. G., Wong, D. H., Higgins, L. S., Vessella, R., Corey, E., Padalecki, S., Suva, L., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1007 · Cited by 539
lncRNA Directs Cooperative Epigenetic Regulation Downstream of Chemokine Signals
Xing, Z., Lin, A., Li, C., Liang, K., Wang, S., Liu, Y., Park, P. K., Qin, L., Wei, Y., Hawke, D. H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.10.013 · Cited by 447
Self-citationZhang, J., Ji, J.-Y., Yu, M., Overholtzer, M., Smolen, G. A., Wang, R., Brugge, J. S., Dyson, N. J., & Haber, D. A. (2009) · Nature Cell Biology · doi:10.1038/ncb1993 · Cited by 424
Long Non-Coding RNAs in the Cytoplasm
Rashid, F., Shah, A., & Shan, G. (2016) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2016.03.005 · Cited by 405
Phosphotyrosine-binding domains in signal transduction
Yaffe, M. B. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm759 · Cited by 366
A genetic screen identifies an LKB1–MARK signalling axis controlling the Hippo–YAP pathway
Mohseni, M., Sun, J., Lau, A., Curtis, S., Goldsmith, J., Fox, V. L., Wei, C., Frazier, M., Samson, O., Wong, K.-K., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb2884 · Cited by 294
A novel family of cell surface receptors with tyrosine kinase-like domain.
Masiakowski, P., & Carroll, R. D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35733-8 · Cited by 272
ROR1 Is Expressed in Human Breast Cancer and Associated with Enhanced Tumor-Cell Growth
Zhang, S., Chen, L., Cui, B., Chuang, H.-Y., Yu, J., Wang-Rodriguez, J., Tang, L., Chen, G., Basak, G. W., & Kipps, T. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031127 · Cited by 260
Self-citationRor receptor tyrosine kinases: orphans no more
Green, J. L., Kuntz, S. G., & Sternberg, P. W. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.08.006 · Cited by 252
Yamaguchi, T., Yanagisawa, K., Sugiyama, R., Hosono, Y., Shimada, Y., Arima, C., Kato, S., Tomida, S., Suzuki, M., Osada, H., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.008 · Cited by 249
Baskar, S., Kwong, K. Y., Hofer, T., Levy, J. M., Kennedy, M. G., Lee, E., Staudt, L. M., Wilson, W. H., Wiestner, A., & Rader, C. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1823 · Cited by 238
Tichon, A., Gil, N., Lubelsky, Y., Havkin Solomon, T., Lemze, D., Itzkovitz, S., Stern-Ginossar, N., & Ulitsky, I. (2016) · Nature Communications · doi:10.1038/ncomms12209 · Cited by 221
The Onco-Embryonic Antigen ROR1 Is Expressed by a Variety of Human Cancers
Zhang, S., Chen, L., Wang-Rodriguez, J., Zhang, L., Cui, B., Frankel, W., Wu, R., & Kipps, T. J. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.08.024 · Cited by 207
Self-citationNSUN6 is a human RNA methyltransferase that catalyzes formation of m5C72 in specific tRNAs
Haag, S., Warda, A. S., Kretschmer, J., Günnigmann, M. A., Höbartner, C., & Bohnsack, M. T. (2015) · RNA · doi:10.1261/rna.051524.115 · Cited by 188
Mapping of MST1 Kinase Sites of Phosphorylation
Glantschnig, H., Rodan, G. A., & Reszka, A. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208538200 · Cited by 184
Bicocca, V. T., Chang, B. H., Masouleh, B. K., Muschen, M., Loriaux, M. M., Druker, B. J., & Tyner, J. W. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.027 · Cited by 170
Tao, J. J., Castel, P., Radosevic-Robin, N., Elkabets, M., Auricchio, N., Aceto, N., Weitsman, G., Barber, P., Vojnovic, B., Ellis, H., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2005125 · Cited by 167
Haskins, J. W., Nguyen, D. X., & Stern, D. F. (2014) · Science Signaling · doi:10.1126/scisignal.2005770 · Cited by 167
Shimo, T., Kubota, S., Yoshioka, N., Ibaragi, S., Isowa, S., Eguchi, T., Sasaki, A., & Takigawa, M. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060416 · Cited by 162
MST kinases in development and disease
Thompson, B. J., & Sahai, E. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201507005 · Cited by 159
ROR1, an embryonic protein with an emerging role in cancer biology
Borcherding, N., Kusner, D., Liu, G.-H., & Zhang, W. (2014) · Protein & Cell · doi:10.1007/s13238-014-0059-7 · Cited by 159
Xue, Z., Hennelly, S., Doyle, B., Gulati, A. A., Novikova, I. V., Sanbonmatsu, K. Y., & Boyer, L. A. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.08.010 · Cited by 159
Heregulin-dependent Activation of Phosphoinositide 3-Kinase and Akt via the ErbB2/ErbB3 Co-receptor
Hellyer, N. J., Kim, M.-S., & Koland, J. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102079200 · Cited by 156
Ror1 Is a Pseudokinase That Is Crucial for Met-Driven Tumorigenesis
Gentile, A., Lazzari, L., Benvenuti, S., Trusolino, L., & Comoglio, P. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2662 · Cited by 138
Oishi, I., Takeuchi, S., Hashimoto, R., Nagabukuro, A., Ueda, T., Liu, Z., Hatta, T., Akira, S., Matsuda, Y., Yamamura, H., et al. (1999) · Genes to Cells · doi:10.1046/j.1365-2443.1999.00234.x · Cited by 135
Src Family Kinases as Novel Therapeutic Targets to Treat Breast Cancer Brain Metastases
Zhang, S., Huang, W.-C., Zhang, L., Zhang, C., Lowery, F. J., Ding, Z., Guo, H., Wang, H., Huang, S., Şahin, A. A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-1803 · Cited by 127
Self-citationBergeron, J. J. M., Guglielmo, G. M. D., Dahan, S., Dominguez, M., & Posner, B. I. (2016) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060815-014659 · Cited by 120
The Ror receptor tyrosine kinase family
Forrester, W. C. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8407-9 · Cited by 109
Yoda, A., Oishi, I., & Minami, Y. (2003) · Journal of Receptors and Signal Transduction · doi:10.1081/rrs-120018757 · Cited by 106
Molecular Mechanisms of Bone Metastasis and Associated Muscle Weakness
Waning, D. L., & Guise, T. A. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1590 · Cited by 101
Expression of ROR1 has prognostic significance in triple negative breast cancer
Chien, H., Ueng, S., Chen, S., Chang, Y., Lin, Y., Lo, Y.-F., Chang, H., Chuang, W., Huang, Y.-T., Cheung, Y., et al. (2016) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-016-1911-3 · Cited by 92
Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies
Daneshmanesh, A. H., Porwit‐MacDonald, A., Hojjat‐Farsangi, M., Jeddi‐Tehrani, M., Tamm, K. P., Grandér, D., Lehmann, S., Norin, S., Shokri, F., Rabbani, H., et al. (2012) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2012.731599 · Cited by 82
The Hippo pathway in disease and therapy: cancer and beyond
Gómez-Ferrer, M., Gómez, V., & Hergovich, A. (2014) · Clinical and Translational Medicine · doi:10.1186/2001-1326-3-22 · Cited by 65
Bae, S. Y., Choi, Y., Kim, S., Kim, M., Kim, J., Jung, S. P., Choi, M.-Y., Lee, S. K., Kil, W. H., Lee, J. E., et al. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2570-6 · Cited by 61
ROR1 is a pseudokinase that is crucial for MET-driven tumorigenesis
Lazzari, L., Gentile, A., Benvenuti, S., Trusolino, L., & Comoglio, P. M. (2013) · BMC Proceedings · doi:10.1186/1753-6561-7-s2-p43 · Cited by 50
Microenvironment Determinants of Brain Metastasis
Zhang, C., & Yu, D. (2011) · Cell & Bioscience · doi:10.1186/2045-3701-1-8 · Cited by 48
The ROR1 pseudokinase diversifies signaling outputs in MET‐addicted cancer cells
Gentile, A., Lazzari, L., Benvenuti, S., Trusolino, L., & Comoglio, P. M. (2014) · International Journal of Cancer · doi:10.1002/ijc.28879 · Cited by 47
Karachaliou, N., Giménez-Capitán, A. A., Drozdowskyj, A., Viteri, S., Morán, T., Carcereny, E., Massutí, B., Vergnenégre, A., de Marinis, F., Molina‐Vila, M. Á., et al. (2014) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2218-6751.2014.03.02 · Cited by 36
Bittner, N., Balikó, Z., Sárosi, V., László, T., Tóth, E., Kásler, M., & Géczi, L. (2015) · Pathology & Oncology Research · doi:10.1007/s12253-015-9955-2 · Cited by 13
Cited by
Long noncoding RNAs in cancer metastasis
Liu, S. J., Dang, H. X., Lim, D. A., Feng, F. Y., & Maher, C. A. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00353-1 · Cited by 648
Ni, W., Yao, S., Zhou, Y., Liu, Y., Huang, P., Zhou, A., Liu, J., Che, L., & Li, J. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1079-y · Cited by 589
Self-citationLong Noncoding RNA in Cancer: Wiring Signaling Circuitry
Lin, C., & Yang, L. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.11.008 · Cited by 488
Self-citationKatoh, M. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4129 · Cited by 465
Glucocorticoids promote breast cancer metastasis
Obradović, M. M. S., Hamelin, B., Manevski, N., Couto, J. P., Sethi, A., Coissieux, M.-M., Münst, S., Okamoto, R., Kohler, H., Schmidt, A., et al. (2019) · Nature · doi:10.1038/s41586-019-1019-4 · Cited by 462
Metadata
- Authors
- Li, C., Wang, S., Xing, Z., Lin, A., Liang, K., Song, J., Hu, Q., Yao, J., Chen, Z., Park, P. K., Hawke, D. H., Zhou, J., Zhou, Y., Zhang, S., Liang, H., Hung, M.-C., Gallick, G. E., Han, L., Lin, C., & Yang, L.
- Venue
- Nature Cell Biology
- Published
- 2017-01-23
- Volume
- 19
- Issue
- 2
- Pages
- 106-119
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2582845364
- Cited by
- 316
- References
- 66
- FWCI
- 16.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.